Accellix - About the company
Accellix is an acquired company based in San Jose (United States), founded in 2007. It operates as a Developer of immunotherapy-based assay delivery platform. Accellix has raised $35.8M in funding from investors like Axcel, BioMerieux and Broadoak Capital Partners. The company has 84 active competitors, including 14 funded and 13 that have exited. Its top competitors include companies like Spear Bio, US BioTek Laboratories and Olink.
Company Details
Accellix is involved in developing immunotherapy-based assay delivery platforms. It consists of dry reagents and a microfluidic cartridge. It offers bead assays, cell assays, and enzymatic PCR. The company also offers services like diluent processing, laser/optics, and photon capture, electronics, and more.
- Website
- www.accellix.com/
- Social
- Phone Number
- +1 **********
Key Metrics
Founded Year
2007
Location
San Jose, United States
Stage
Acquired
Total Funding
$35.8M in 10 rounds
Latest Funding Round
Ranked
3rd among 84 active competitors
Employee Count
60 as on Aug 31, 2026
Exit Details
Acquired by BioMerieux (Jan 22, 2026)
Accellix's acquisition details
Accellix got acquired by BioMerieux on Jan 22, 2026 at an acquisition amount of $*****.
Click here to take a look at Accellix's acquisition in detail
Sign up to download Accellix's company profile
Accellix's funding and investors
Accellix has raised a total funding of $35.8M over 10 rounds. Its first funding round was on Jul 13, 2009. Its latest funding round was a Series D round on Dec 13, 2021 for $*****. 1 investor participated in its latest round. Accellix has 4 institutional investors.
Here is the list of recent funding rounds of Accellix:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 13, 2021 | 4702404 | Series D | 3726057 | 4630317 | 6620485 | 7730190 |
Jul 15, 2020 | 2823871 | Series D | 5471896 | 6215913 | 9957374 | 9868914 |
Jun 11, 2020 | 3561318 | Series D | 1052485 | 7270976 | 7474655 |
Access funding benchmarks and valuations. Sign up today!View details of Accellix's funding rounds and investors
Accellix's founders and board of directors
Founder? Claim ProfileAccellix's employee count trend
Accellix has 60 employees as of Aug 26. Here is Accellix's employee count trend over the years:
Uncover Accellix's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Accellix's Competitors and alternates
Top competitors of Accellix include Spear Bio, US BioTek Laboratories and Olink. Here is the list of Top 10 competitors of Accellix, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Spear Bio 2021, Boston (United States), Series A | Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers | $49M | 62/100 | |
2nd | US BioTek Laboratories 2008, Shoreline (United States), Acquired | Provider of enzyme-linked immunosorbent assay technology services | $19.5M | 60/100 | |
3rd |  Accellix 2007, San Jose (United States), Acquired | Developer of immunotherapy-based assay delivery platform | $35.8M | 59/100 | |
4th | Provider of products and services for human protein biomarker research and development | - | 53/100 | ||
5th | SurModics 1979, Eden Prairie (United States), Acquired | Manufacturer of medical device coatings specialty polymers and diagnostic materials | - | - | 53/100 |
6th |  ProAxsis 2013, Belfast (United Kingdom), Acquired | Developer of diagnostic test for the detection of respiratory conditions | $2.79M | 52/100 | |
7th | Presage Biosciences 2008, Seattle (United States), Series E | Translational oncology company pioneering drug development with its CIVO platform | $35M | 47/100 | |
8th |  Correlia Biosystems 2013, Berkeley (United States), Series A | Developer of immunoassay platforms to quantify proteins for proteomics and pharmaceutical applications | $10.9M | 45/100 | |
9th |  Immunicom 2013, San Diego (United States), Series B | Developer of a immunotherapy device | $21.9M | 43/100 | |
10th | Point-of-care in vitro diagnostics for immunoassays | $10M | 42/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Accellix's competitors? Click here to see the top ones
Accellix's Investments and acquisitions
Accellix has made no investments or acquisitions yet.
Reports related to Accellix
Here is the latest report on Accellix's sector:
News related to Accellix
Filter this listMedia has covered Accellix for 1 event in last 1 year.
•
bioMérieux acquires Accellix for €35M to enhance cell and gene therapy quality controlNewsnReleases•Jan 22, 2026•BioMerieux, Accellix
•
Accellix appoints Dr. Félix A. Montero-Julian Vice President of Scientific AffairsBusiness Wire•Jul 08, 2025•Accellix
•
•
Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank MarketsBusiness Wire•Sep 23, 2024•Accellix
•
Accellix Raises $10 Million From BroadOak Capital PartnersBusiness Wire•Dec 13, 2021•Accellix, Broadoak Capital Partners
•
•
Accellix, the Cell Therapy QC Company Raises $9.5 Million Series D RoundBusiness Wire•Jun 11, 2020•BioMerieux, Accellix, Pearl Cohen
•
•
•
Orgenesis Announces Co-Development Agreement with AccellixGlobeNewswire•Oct 16, 2019•Accellix, Orgenesis, accelix.com
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Accellix
Explore our recently published companies
- Health Works - Bryan based, Unfunded company
- SRITECH - Nagpur based, 1995 founded, Unfunded company
- Witte Werbetechnik - Amelinghausen based, Unfunded company
- Nexarcane Forensics & Technology - Bengaluru based, 2024 founded, Unfunded company
- Parna Creations - Shivamogga based, 2023 founded, Unfunded company
- CITYX Super App - Bengaluru based, 2021 founded, Unfunded company
